322 related articles for article (PubMed ID: 26122357)
1. Monitoring regulatory T cells in clinical samples: consensus on an essential marker set and gating strategy for regulatory T cell analysis by flow cytometry.
Santegoets SJ; Dijkgraaf EM; Battaglia A; Beckhove P; Britten CM; Gallimore A; Godkin A; Gouttefangeas C; de Gruijl TD; Koenen HJ; Scheffold A; Shevach EM; Staats J; Taskén K; Whiteside TL; Kroep JR; Welters MJ; van der Burg SH
Cancer Immunol Immunother; 2015 Oct; 64(10):1271-86. PubMed ID: 26122357
[TBL] [Abstract][Full Text] [Related]
2. Isolation strategies of regulatory T cells for clinical trials: phenotype, function, stability, and expansion capacity.
Ukena SN; Höpting M; Velaga S; Ivanyi P; Grosse J; Baron U; Ganser A; Franzke A
Exp Hematol; 2011 Dec; 39(12):1152-60. PubMed ID: 21864487
[TBL] [Abstract][Full Text] [Related]
3. Identification of circulating regulatory T lymphocytes with membrane markers - a new multiparameter flow cytometry protocol.
Piekarska A; Pérès M; Toton M; Kulczycka M; Lewandowski K; Vergez F
Folia Histochem Cytobiol; 2021; 59(2):75-85. PubMed ID: 34097299
[TBL] [Abstract][Full Text] [Related]
4. Expansion of human regulatory T-cells from patients with type 1 diabetes.
Putnam AL; Brusko TM; Lee MR; Liu W; Szot GL; Ghosh T; Atkinson MA; Bluestone JA
Diabetes; 2009 Mar; 58(3):652-62. PubMed ID: 19074986
[TBL] [Abstract][Full Text] [Related]
5. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
6. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
[TBL] [Abstract][Full Text] [Related]
7. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
[TBL] [Abstract][Full Text] [Related]
8. Ex-vivo characterization of regulatory T cells in pulmonary tuberculosis patients, latently infected persons, and healthy endemic controls.
Zewdie M; Howe R; Hoff ST; Doherty TM; Getachew N; Tarekegne A; Tessema B; Yamuah L; Aseffa A; Abebe M
Tuberculosis (Edinb); 2016 Sep; 100():61-68. PubMed ID: 27553411
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal cells recruit and regulate T regulatory cells.
Di Ianni M; Del Papa B; De Ioanni M; Moretti L; Bonifacio E; Cecchini D; Sportoletti P; Falzetti F; Tabilio A
Exp Hematol; 2008 Mar; 36(3):309-18. PubMed ID: 18279718
[TBL] [Abstract][Full Text] [Related]
10. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients.
Roschupkina T; Juliusson G
Cytometry B Clin Cytom; 2018 Mar; 94(2):264-269. PubMed ID: 27479496
[TBL] [Abstract][Full Text] [Related]
11. A modified flow cytometry method for objective estimation of human CD4
Petsiou A; Paschou SA; Vartholomatos G; Chatzigianni K; Kolaitis N; Giotaki E; Bondinas GP; Moustakas AK; Karamoutsios A; Zervou E; Tigas S; Tsatsoulis A; Papadopoulos GK
Cytometry B Clin Cytom; 2020 May; 98(3):259-269. PubMed ID: 31571372
[TBL] [Abstract][Full Text] [Related]
12. Reduced frequency and functional defects of CD4
Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
[TBL] [Abstract][Full Text] [Related]
13. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
14. CD45RA Distinguishes CD4+CD25+CD127-/low TSDR Demethylated Regulatory T Cell Subpopulations With Differential Stability and Susceptibility to Tacrolimus-Mediated Inhibition of Suppression.
Arroyo Hornero R; Betts GJ; Sawitzki B; Vogt K; Harden PN; Wood KJ
Transplantation; 2017 Feb; 101(2):302-309. PubMed ID: 28118317
[TBL] [Abstract][Full Text] [Related]
15. Multiple sclerosis patients have reduced resting and increased activated CD4
Verma ND; Lam AD; Chiu C; Tran GT; Hall BM; Hodgkinson SJ
Sci Rep; 2021 May; 11(1):10476. PubMed ID: 34006899
[TBL] [Abstract][Full Text] [Related]
16. T regulatory cells in cord blood--FOXP3 demethylation as reliable quantitative marker.
Liu J; Lluis A; Illi S; Layland L; Olek S; von Mutius E; Schaub B
PLoS One; 2010 Oct; 5(10):e13267. PubMed ID: 20967272
[TBL] [Abstract][Full Text] [Related]
17. Altered Suppressor Function of Regulatory T Cells in Type 1 Diabetes.
Aghili B; Amirzargar AA; Rajab A; Rabbani A; Sotoudeh A; Assadiasl S; Larijani B; Massoud A
Iran J Immunol; 2015 Dec; 12(4):240-51. PubMed ID: 26714416
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+CD127low FoxP3+ regulatory T cells in Crohn's disease.
Khalili A; Ebrahimpour S; Maleki I; Abediankenari S; Afrouzi MM
Rom J Intern Med; 2018 Sep; 56(3):158-166. PubMed ID: 29453928
[TBL] [Abstract][Full Text] [Related]
19. Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation.
Nafady-Hego H; Li Y; Ohe H; Elgendy H; Zhao X; Sakaguchi S; Bishop GA; Koshiba T
Transpl Immunol; 2016 May; 36():1-8. PubMed ID: 27105585
[TBL] [Abstract][Full Text] [Related]
20. The human "Treg MLR": immune monitoring for FOXP3+ T regulatory cell generation.
Levitsky J; Miller J; Leventhal J; Huang X; Flaa C; Wang E; Tambur A; Burt RK; Gallon L; Mathew JM
Transplantation; 2009 Dec; 88(11):1303-11. PubMed ID: 19996930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]